Inventor · disambiguated record
Ana Maria Buj Bello
Also filed as: BUJ BELLO ANA · BUJ BELLO ANA MARIA
11 granted patents·6 pending applications·20 citations·filing 2014–2021
86Inventor score
Top patents by PatentIndex Score
17 records- 0191US9415120B2Systemic gene replacement therapy for treatment of X-linked MyoTubular Myopathy (XLMTM)UNIV WAKE FOREST HEALTH SCIENCES·Filed 2015·Granted Aug 16, 2016·5 cites·31 claims
- 0289US8957044B2Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)UNIV WAKE FOREST HEALTH SCIENCES·Filed 2014·Granted Feb 17, 2015·6 cites·15 claims
- 0388US9895426B2Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)UNIV WAKE FOREST HEALTH SCIENCES·Filed 2016·Granted Feb 20, 2018·3 cites·56 claims
- 0488US9839677B2Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)UNIV WAKE FOREST HEALTH SCIENCES·Filed 2016·Granted Dec 12, 2017·3 cites·10 claims
- 0586US11564977B2Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)UNIV WAKE FOREST HEALTH SCIENCES·Filed 2017·Granted Jan 31, 2023·2 cites·36 claims
- 0672US12178856B2Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)UNIV WAKE FOREST HEALTH SCIENCES·Filed 2020·Granted Dec 31, 2024·0 cites·10 claims
- 0769US9981049B2Selective gene therapy expression systemGENETHON·Filed 2014·Granted May 29, 2018·1 cites·10 claims
- 0864US11819478B2Selective gene therapy expression systemGENETHON·Filed 2018·Granted Nov 21, 2023·0 cites·16 claims
- 0953US2023173102A1Use of a Synthetic AAV Capsid for Gene Therapy of Muscle and Central Nervous System DisordersGENETHON·Filed 2021·Application pending·0 cites
- 1051US2022042045A1Expression cassettes for gene therapy vectorsGENETHON·Filed 2019·Application pending·0 cites
- 1149US11499154B2Antisense targeting dynamin 2 and use for the treatment of centronuclear myopathies and neuropathiesGENETHON·Filed 2018·Granted Nov 15, 2022·0 cites·14 claims
- 1248US2023151390A1Vectors for the treatment of acid ceramidase deficiencyGENETHON·Filed 2021·Application pending·0 cites
- 1344US11104897B2Compositions and methods for the treatment of nucleotide repeat expansion disordersGENETHON·Filed 2016·Granted Aug 31, 2021·0 cites·16 claims
- 1441US11427824B2Compositions and methods for the treatment of myotonic dystrophyGENETHON·Filed 2017·Granted Aug 30, 2022·0 cites·22 claims
- 1539US2020370069A1Treatment of spinal muscular atrophyGENETHON·Filed 2018·Application pending·0 cites
- 1633US2019256868A1Compositions and methods for the treatment of myotonic dystrophyGENETHON·Filed 2017·Application pending·0 cites
- 1732US2017071972A1Method of treating peripheral neuropathies and motor neuron diseasesGENETHON·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →